Apia Politics Week: Press Releases

Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe

Teva and Prestige announce a license and supply agreement for the commercialization of Prestige’s Tuznue®, a biosimilar to Herceptin® (trastuzumab) Tuznue® received European Commission (EC) marketing authorization in September 2024 Partnership brings …

Nutex Health Inc. Class Action: Levi & Korsinsky Reminds Nutex Health Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2025 – NUTX

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

Investors in aTyr Pharma, Inc. Should Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights – ATYR

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

Shareholders that lost money on Semler Scientific, Inc.(SMLR) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

LifeMD, Inc. Class Action: Levi & Korsinsky Reminds LifeMD, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 25, 2025 – LFMD

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

Levi & Korsinsky Notifies Shareholders of PubMatic, Inc.(PUBM) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

Levi & Korsinsky Notifies Fortinet, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – FTNT

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2025 in C3.ai Lawsuit – AI

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

Shareholders of Fly-E Group, Inc. Should Contact Levi & Korsinsky Before November 10, 2025 to Discuss Your Rights – FLYE

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

Levi & Korsinsky Reminds Tronox Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 3, 2025 – TROX

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

Snap Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – SNAP

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

November 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against FLR

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

Class Action Filed Against Lantheus Holdings, Inc. (LNTH) - November 10, 2025 Deadline to Join – Contact Levi & Korsinsky

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

Levi & Korsinsky Reminds Dow Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2025 – DOW

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

WPP plc Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights – WPP

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

KBR, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – KBR

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025 – SVRA

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

V.F. Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – VFC

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

Shareholders that lost money on Cytokinetics, Incorporated(CYTK) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi …

Vicor steps up its IP licensing practice

ANDOVER, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Vicor Corporation (NASDAQ: VICR) Intellectual Property (IP) stemming from Vicor’s development of high-density power system technology is key to performance in high growth markets such as AI. Licensed access …